26 results on '"Bagaria, J"'
Search Results
2. COVID-19 deaths in children: comparison with all- and other causes and trends in incidence of mortality
- Author
-
Bhopal, S.S., Bagaria, J., Olabi, B., and Bhopal, R.
- Published
- 2020
- Full Text
- View/download PDF
3. Baseline results of a living systematic review for COVID-19 clinical trial registrations.
- Author
-
Maguire, BJ, McLean, ARD, Rashan, S, Antonio, ES, Bagaria, J, Bentounsi, Z, Brack, M, Caldwell, F, Carrara, VI, Citarella, BW, Dahal, P, Feteh, VF, H B Guérin, M, Kennon, K, Bilton Lahaut, K, Makuka, GJ, Ngu, R, Obiesie, S, Richmond, C, Singh-Phulgenda, S, Strudwick, S, Tyrrell, CSB, Schwinn, A, King, D, Newton, PN, Price, RN, Merson, L, Stepniewska, K, Guérin, PJ, Maguire, BJ, McLean, ARD, Rashan, S, Antonio, ES, Bagaria, J, Bentounsi, Z, Brack, M, Caldwell, F, Carrara, VI, Citarella, BW, Dahal, P, Feteh, VF, H B Guérin, M, Kennon, K, Bilton Lahaut, K, Makuka, GJ, Ngu, R, Obiesie, S, Richmond, C, Singh-Phulgenda, S, Strudwick, S, Tyrrell, CSB, Schwinn, A, King, D, Newton, PN, Price, RN, Merson, L, Stepniewska, K, and Guérin, PJ
- Abstract
Background: Since the coronavirus disease 2019 (COVID-19) outbreak was first reported in December 2019, many independent trials have been planned that aim to answer similar questions. Tools allowing researchers to review studies already underway can facilitate collaboration, cooperation and harmonisation. The Infectious Diseases Data Observatory (IDDO) has undertaken a living systematic review (LSR) to provide an open, accessible and frequently updated resource summarising characteristics of COVID-19 study registrations. Methods: Review of all eligible trial records identified by systematic searches as of 3 April 2020 and initial synthesis of clinical study characteristics were conducted. In partnership with Exaptive, an open access, cloud-based knowledge graph has been created using the results. Results: There were 728 study registrations which met eligibility criteria and were still active. Median (25 th, 75 th percentile) sample size was 130 (60, 400) for all studies and 134 (70, 300) for RCTs. Eight lower middle and low income countries were represented among the planned recruitment sites. Overall 109 pharmacological interventions or advanced therapy medicinal products covering 23 drug categories were studied. Majority (57%, 62/109) of them were planned only in one study arm, either alone or in combination with other interventions. There were 49 distinct combinations studied with 90% (44/49) of them administered in only one or two study arms. The data and interactive platform are available at https://iddo.cognitive.city/. Conclusions: Baseline review highlighted that the majority of investigations in the first three months of the outbreak were small studies with unique treatment arms, likely to be unpowered to provide solid evidence. The continued work of this LSR will allow a more dependable overview of interventions tested, predict the likely strength of evidence generated, allow fast and informative filtering of relevant trials for specific user groups and
- Published
- 2020
4. Children's mortality from COVID-19 compared with all-deaths and other relevant causes of death: epidemiological information for decision-making by parents, teachers, clinicians and policymakers
- Author
-
Bhopal, S., primary, Bagaria, J., additional, and Bhopal, R., additional
- Published
- 2020
- Full Text
- View/download PDF
5. Health Impacts of Catastrophic Climate Change: Expert Workshop. Avoid Dangerous Climate Change (AVOID)
- Author
-
Kovats, S, Ebi, K, Annunziata, G, Bagaria, J, Banatvala, N, Baschieri, A, Campbell-Lendrum, D, Chalabi, Z, Chand, S, Clark, J, Downing, T, Frame, D, Gosling, S, Grynszpan, D, Haines, A, Hayes, L, Hemming, D, Leonardi, G, Lowe, J, Menne, B, Nerlander, L, Ranger, N, Scaramella, C, Sondorp, E, Tacoli, C, van der Linden, P, Warren, R, and Zanev, C
- Abstract
Climate change is likely to have serious and significant impacts on human population health. The mechanisms by which climate change may affect health are becoming better understood. Current quantitative methods of estimating future health impacts rely on disease-specific models that primarily describe relationships between mean values of weather variables and health outcomes and do not address the impacts of extreme events or weather disasters. Extreme events have the potential to disrupt community function, which is of concern for decision-makers. Estimating the magnitude and extent of impacts from low probability high impact events is challenging because there is often no analogue that can provide relevant evidence and that take into account the complexity of factors determining future vulnerability and health impacts (the social determinants of health).
- Published
- 2016
- Full Text
- View/download PDF
6. Radiochemical synthesis of105gAg-labelled silver nanoparticles
- Author
-
European Commission, Ichedef, C., Puntes, Víctor F., Bagaria, J. P., European Commission, Ichedef, C., Puntes, Víctor F., and Bagaria, J. P.
- Abstract
A method for synthesis of radiolabelled silver nanoparticles is reported. The method is based on proton activation of silver metal powder, enriched in 107Ag, with a 30.7 MeV proton beam. At this proton energy 105gAg is efficiently created, mainly via the 107Ag(p,3n)105Cd → 105gAg reaction. 105gAg has a half-life of 41.29 days and emits easily detectable gamma radiation on decay to 105Pd. This makes it very useful as a tracing radionuclide for experiments over several weeks or months. Following activation and a period to allow short-lived radionuclides to decay, the powder was dissolved in concentrated nitric acid in order to form silver nitrate (AgNO3), which was used to synthesise radiolabelled silver nanoparticles via the process of sodium borohydride reduction. For comparison, non-radioactive silver nanoparticles were synthesised using commercially supplied AgNO3 in order to check if the use of irradiated Ag powder as a starting material would alter in any way the final nanoparticle characteristics. Both nanoparticle types were characterised using dynamic light scattering, zeta-potential and X-ray diffraction measurements, while additionally the non-radioactive samples were analysed by transmission electron microscopy and UV–Vis spectrometry. A hydrodynamic diameter of about 16 nm was determined for both radiolabelled and non-radioactive nanoparticles, while the electron microscopy on the non-radioactive samples indicated that the physical size of the metal NPs was (7.3 ± 1.4) nm.
- Published
- 2013
7. The need for commissioning circumcision services for non-therapeutic indications in the NHS: lessons from an incident investigation in Oxford
- Author
-
Paranthaman, K., primary, Bagaria, J., additional, and O'Moore, E., additional
- Published
- 2010
- Full Text
- View/download PDF
8. Pertussis: A cluster of linked cases in the United Kingdom, 2006
- Author
-
Weerasinghe, C, primary, Fernandes, A, additional, and Bagaria, J, additional
- Published
- 2007
- Full Text
- View/download PDF
9. Hepatitis A cases in a travelling community in southeast England
- Author
-
Carnicer-Pont, D, primary, Bagaria, J, additional, Paranthaman, K, additional, Smith, Alyson, additional, Barber, S, additional, and Bernhaut, J, additional
- Published
- 2006
- Full Text
- View/download PDF
10. Radiochemical synthesis of 105gAg-labelled silver nanoparticles.
- Author
-
Ichedef, C., Simonelli, F., Holzwarth, U., Bagaria, J. Piella, Puntes, V. F., Cotogno, G., Gilliland, D., and Gibson, N.
- Subjects
GOLD nanoparticle synthesis ,RADIOCHEMISTRY ,NANOSTRUCTURED materials synthesis ,SILVER nanoparticles ,METAL powders ,CHEMICAL reactions ,BOROHYDRIDE ,CHEMICAL reduction ,X-ray diffraction - Abstract
A method for synthesis of radiolabelled silver nanoparticles is reported. The method is based on proton activation of silver metal powder, enriched in
107 Ag, with a 30.7 MeV proton beam. At this proton energy105g Ag is efficiently created, mainly via the107 Ag(p,3n)105 Cd →105g Ag reaction.105g Ag has a half-life of 41.29 days and emits easily detectable gamma radiation on decay to105 Pd. This makes it very useful as a tracing radionuclide for experiments over several weeks or months. Following activation and a period to allow short-lived radionuclides to decay, the powder was dissolved in concentrated nitric acid in order to form silver nitrate (AgNO3 ), which was used to synthesise radiolabelled silver nanoparticles via the process of sodium borohydride reduction. For comparison, non-radioactive silver nanoparticles were synthesised using commercially supplied AgNO3 in order to check if the use of irradiated Ag powder as a starting material would alter in any way the final nanoparticle characteristics. Both nanoparticle types were characterised using dynamic light scattering, zeta-potential and X-ray diffraction measurements, while additionally the non-radioactive samples were analysed by transmission electron microscopy and UV–Vis spectrometry. A hydrodynamic diameter of about 16 nm was determined for both radiolabelled and non-radioactive nanoparticles, while the electron microscopy on the non-radioactive samples indicated that the physical size of the metal NPs was (7.3 ± 1.4) nm. [ABSTRACT FROM AUTHOR]- Published
- 2013
- Full Text
- View/download PDF
11. Evacuation and sheltering of hospitals in emergencies: a review of international experience.
- Author
-
Bagaria J, Heggie C, Abrahams J, Murray V, Bagaria, Jayshree, Heggie, Caroline, Abrahams, Jonathan, and Murray, Virginia
- Published
- 2009
- Full Text
- View/download PDF
12. Bounded forcing axioms and the continuum
- Author
-
Aspero, D. and Bagaria, J.
- Published
- 2001
- Full Text
- View/download PDF
13. Generic absoluteness
- Author
-
Bagaria, J. and Friedman, S. D.
- Published
- 2001
- Full Text
- View/download PDF
14. Genetics, Functions, and Clinical Impact of Presenilin-1 (PSEN1) Gene.
- Author
-
Bagaria J, Bagyinszky E, and An SSA
- Subjects
- Humans, Amyloid Precursor Protein Secretases genetics, Amyloid Precursor Protein Secretases metabolism, Cadherins genetics, Calcium, Mutation, Presenilin-1 genetics, Presenilin-2 genetics, Alzheimer Disease metabolism, Amyloid beta-Protein Precursor genetics
- Abstract
Presenilin-1 (PSEN1) has been verified as an important causative factor for early onset Alzheimer's disease (EOAD). PSEN1 is a part of γ-secretase, and in addition to amyloid precursor protein (APP) cleavage, it can also affect other processes, such as Notch signaling, β-cadherin processing, and calcium metabolism. Several motifs and residues have been identified in PSEN1, which may play a significant role in γ-secretase mechanisms, such as the WNF, GxGD, and PALP motifs. More than 300 mutations have been described in PSEN1; however, the clinical phenotypes related to these mutations may be diverse. In addition to classical EOAD, patients with PSEN1 mutations regularly present with atypical phenotypic symptoms, such as spasticity, seizures, and visual impairment. In vivo and in vitro studies were performed to verify the effect of PSEN1 mutations on EOAD. The pathogenic nature of PSEN1 mutations can be categorized according to the ACMG-AMP guidelines; however, some mutations could not be categorized because they were detected only in a single case, and their presence could not be confirmed in family members. Genetic modifiers, therefore, may play a critical role in the age of disease onset and clinical phenotypes of PSEN1 mutations. This review introduces the role of PSEN1 in γ-secretase, the clinical phenotypes related to its mutations, and possible significant residues of the protein.
- Published
- 2022
- Full Text
- View/download PDF
15. Whole Exome Sequencing Reveals a Novel APOE Mutation in a Patient With Sporadic Early-Onset Alzheimer's Disease.
- Author
-
Bagaria J, Moon Y, Bagyinszky E, Shim KH, An SSA, Kim S, and Han SH
- Abstract
Apolipoprotein (APOE) is implicated and verified as the main risk factor for early-onset Alzheimer's disease (AD). APOE is a protein that binds to lipids and is involved in cholesterol stability. Our paper reports a case of a sporadic early-onset AD (sEOAD) patient of a 54-year-old Korean man, where a novel APOE Leu159Pro heterozygous mutation was revealed upon Whole Exome Sequence analysis. The proband's CSF showed downregulated levels of Aβ42, with unchanged Tau levels. The mutation is in the Low-Density Lipoprotein Receptor (LDLR) region of the APOE gene, which mediates the clearance of APOE lipoproteins. LDLR works as a high-affinity point for APOE. Studies suggest that APOE-LDLR interplay could have varying effects. The LDLR receptor pathway has been previously suggested as a therapeutic target to treat tauopathy. However, the APOE-LDLR interaction has also shown a significant correlation with memory retention. Leu159Pro could be an interesting mutation that could be responsible for a less damaging pattern of AD by suppressing tau-association neurodegeneration while affecting the patient's memory retention and cognitive performance., Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2022 Bagaria, Moon, Bagyinszky, Shim, An, Kim and Han.)
- Published
- 2022
- Full Text
- View/download PDF
16. Rapidly adapting primary care sentinel surveillance across seven countries in Europe for COVID-19 in the first half of 2020: strengths, challenges, and lessons learned.
- Author
-
Bagaria J, Jansen T, Marques DF, Hooiveld M, McMenamin J, de Lusignan S, Vilcu AM, Meijer A, Rodrigues AP, Brytting M, Mazagatos C, Cogdale J, van der Werf S, Dijkstra F, Guiomar R, Enkirch T, and Valenciano M
- Subjects
- Europe epidemiology, Humans, Pandemics prevention & control, Primary Health Care, Sentinel Surveillance, COVID-19 epidemiology, Influenza Vaccines, Influenza, Human epidemiology, Influenza, Human prevention & control
- Abstract
As the COVID-19 pandemic began in early 2020, primary care influenza sentinel surveillance networks within the Influenza - Monitoring Vaccine Effectiveness in Europe (I-MOVE) consortium rapidly adapted to COVID-19 surveillance. This study maps system adaptations and lessons learned about aligning influenza and COVID-19 surveillance following ECDC / WHO/Europe recommendations and preparing for other diseases possibly emerging in the future. Using a qualitative approach, we describe the adaptations of seven sentinel sites in five European Union countries and the United Kingdom during the first pandemic phase (March-September 2020). Adaptations to sentinel systems were substantial (2/7 sites), moderate (2/7) or minor (3/7 sites). Most adaptations encompassed patient referral and sample collection pathways, laboratory testing and data collection. Strengths included established networks of primary care providers, highly qualified testing laboratories and stakeholder commitments. One challenge was the decreasing number of samples due to altered patient pathways. Lessons learned included flexibility establishing new routines and new laboratory testing. To enable simultaneous sentinel surveillance of influenza and COVID-19, experiences of the sentinel sites and testing infrastructure should be considered. The contradicting aims of rapid case finding and contact tracing, which are needed for control during a pandemic and regular surveillance, should be carefully balanced.
- Published
- 2022
- Full Text
- View/download PDF
17. Discriminating Potential Genetic Markers for Complete Response and Non-Complete Response Patients to Neoadjuvant Chemotherapy with Locally Advanced Rectal Cancer.
- Author
-
Bagaria J, Kim KO, Bagyinszky E, An SSA, and Baek JH
- Subjects
- Chemoradiotherapy, Genetic Markers, Humans, Microfilament Proteins genetics, Neoadjuvant Therapy, Receptors, Cell Surface genetics, Treatment Outcome, Neoplasms, Second Primary, Rectal Neoplasms genetics, Rectal Neoplasms therapy
- Abstract
Background: Neoadjuvant chemoradiotherapy (nCRT) prior to surgery is considered standard therapy for locally advanced rectal cancer. Unfortunately, most patients with rectal cancer are resistant to radiotherapy. This might be a genetic cause. The role of certain rectal cancer-causing genes has not been completely elucidated. This study aims to investigate the genes responsible for locally advanced rectal cancer patients not reacting to radiotherapy. Methods: Whole exome sequencing of the DNA samples was performed on the samples. Bioinformatic analysis on the subjects was established. Individual genetic information was screened to identify differently expressed genes that more frequently appeared in non-complete response (NCR) compared to complete response (CR) patients after nCRT. All variations were verified by Sanger sequencing. Results: Genotyping information and pathway analyses of the samples indicated genes such as FLCN, CALML5, and ANTXR1 to be commonly mutated in CR group, whereas genes such as GALNTL14, CNKSR1, ACD, and CUL3 were more commonly mutated in the NCR group. Chi-square test revealed some significant variants (<0.05) such as rs3744124 (FLCN), rs28365986 (ANTXR1), rs10904516 (CALML5), rs3738952 (CUL3), rs13394 and rs2293013 (PIH1D1), rs2274531 (GPA33), rs4963048 (BRSK2), rs17883366 (IL3RA), rs2297575 (PSMD5), rs2288101 (GALNT14), and rs11954652 (DCTN4). Conclusion: Identifying an array of genes that separate NCRs from CRs would lead to finding genetic biomarkers for early detection of rectal cancer patients that are resistant to nCRT. A further investigation to validate the significance of genetic biomarkers to segregate NCRs from CRs should be performed with a larger CRC dataset. Protein expression levels, as well as transcriptomic analysis, would also help us understand the mechanism of how these genes could play a role in preventing radiation therapy to patients. This would be essential to prevent redundant radiation therapy.
- Published
- 2022
- Full Text
- View/download PDF
18. Genetics of Autosomal Recessive Spastic Ataxia of Charlevoix-Saguenay (ARSACS) and Role of Sacsin in Neurodegeneration.
- Author
-
Bagaria J, Bagyinszky E, and An SSA
- Subjects
- Alleles, Amino Acid Substitution, Animals, Brain metabolism, Brain pathology, Disease Management, Gene Expression Regulation, Genetic Association Studies, Genotype, Heat-Shock Proteins chemistry, Heat-Shock Proteins metabolism, Humans, Mitochondria metabolism, Muscle Spasticity therapy, Mutation, Neurodegenerative Diseases diagnosis, Protein Interaction Domains and Motifs, Spinocerebellar Ataxias diagnosis, Spinocerebellar Ataxias genetics, Spinocerebellar Ataxias therapy, Genetic Predisposition to Disease, Heat-Shock Proteins genetics, Muscle Spasticity diagnosis, Muscle Spasticity genetics, Neurodegenerative Diseases etiology, Phenotype, Spinocerebellar Ataxias congenital
- Abstract
Autosomal recessive spastic ataxia of Charlevoix-Saguenay (ARSACS) is an early-onset neurodegenerative disease that was originally discovered in the population from the Charlevoix-Saguenay-Lac-Saint-Jean (CSLSJ) region in Quebec. Although the disease progression of ARSACS may start in early childhood, cases with later onset have also been observed. Spasticity and ataxia could be common phenotypes, and retinal optic nerve hypermyelination is detected in the majority of patients. Other symptoms, such as pes cavus, ataxia and limb deformities, are also frequently observed in affected individuals. More than 200 mutations have been discovered in the SACS gene around the world. Besides French Canadians, SACS genetics have been extensively studied in Tunisia or Japan. Recently, emerging studies discovered SACS mutations in several other countries. SACS mutations could be associated with pathogenicity either in the homozygous or compound heterozygous stages. Sacsin has been confirmed to be involved in chaperon activities, controlling the microtubule balance or cell migration. Additionally, sacsin may also play a crucial role in regulating the mitochondrial functions. Through these mechanisms, it may share common mechanisms with other neurodegenerative diseases. Further studies are needed to define the exact functions of sacsin. This review introduces the genetic mutations discovered in the SACS gene and discusses its pathomechanisms and its possible involvement in other neurodegenerative diseases.
- Published
- 2022
- Full Text
- View/download PDF
19. Population perspective comparing COVID-19 to all and common causes of death during the first wave of the pandemic in seven European countries.
- Author
-
Olabi B, Bagaria J, Bhopal SS, Curry GD, Villarroel N, and Bhopal R
- Abstract
Objectives: Mortality statistics on the COVID-19 pandemic have led to widespread concern and fear. To contextualise these data, we compared mortality related to COVID-19 during the first wave of the pandemic across seven countries in Europe with all and common causes of death, stratifying by age and sex. We also calculated deaths as a proportion of the population by age and sex., Study Design: Analysis of population mortality data., Methods: COVID-19 related mortality and population statistics from seven European countries were extracted: England and Wales, Italy, Germany, Spain, France, Portugal and Netherlands. Available data spanned 14-16 weeks since the first recorded deaths in each country, except Spain, where only comparable stratified data over an 8-week time period was available. The Global Burden of Disease database provided data on all deaths and those from pneumonia, cardiovascular disease combining ischaemic heart disease and stroke, chronic obstructive pulmonary disease, cancer, road traffic accidents and dementia in 2017., Results: Deaths related to COVID-19, while modest overall, varied considerably by age. Deaths as a percentage of all cause deaths during the time period under study ranged from <0.01% in children in Germany, Portugal and Netherlands, to as high as 41.65% for men aged over 80 years in England and Wales. The percentage of the population who died from COVID-19 was less than 0.2% in every age group under the age of 80. In each country, over the age of 80, these proportions were: England and Wales 1.27% males, 0.87% females; Italy 0.6% males, 0.38% females; Germany 0.13% males, 0.09% females; France 0.39% males, 0.2% females; Portugal 0.2% males, 0.15% females; and Netherlands 0.6% males, 0.4% females., Conclusions: Mortality rates from COVID-19 during the first wave of the pandemic were low including when compared to other common causes of death and are likely to decline further while control measures are maintained, treatments improve and vaccination is instituted. These data may help people to contextualise their risk and for decision-making by policymakers., Competing Interests: None reported., (© 2021 The Author(s).)
- Published
- 2021
- Full Text
- View/download PDF
20. Children and young people remain at low risk of COVID-19 mortality.
- Author
-
Bhopal SS, Bagaria J, Olabi B, and Bhopal R
- Subjects
- Adolescent, Age Distribution, Child, Child, Preschool, Europe epidemiology, Humans, Infant, Infant, Newborn, Pandemics, Republic of Korea epidemiology, Risk Factors, SARS-CoV-2, United States epidemiology, Young Adult, COVID-19 mortality
- Published
- 2021
- Full Text
- View/download PDF
21. Risks to children during the covid-19 pandemic: some essential epidemiology.
- Author
-
Bhopal SS, Bagaria J, and Bhopal R
- Subjects
- Adolescent, Betacoronavirus, COVID-19, Child, Child, Preschool, Coronavirus Infections mortality, Decision Making, Humans, Infant, Infant, Newborn, Pandemics, Pneumonia, Viral mortality, Risk Factors, SARS-CoV-2, Young Adult, Coronavirus Infections epidemiology, Pneumonia, Viral epidemiology, Risk Assessment
- Abstract
Competing Interests: Competing interests: None declared.
- Published
- 2020
- Full Text
- View/download PDF
22. Baseline results of a living systematic review for COVID-19 clinical trial registrations.
- Author
-
Maguire BJ, McLean ARD, Rashan S, Antonio ES, Bagaria J, Bentounsi Z, Brack M, Caldwell F, Carrara VI, Citarella BW, Dahal P, Feteh VF, H B Guérin M, Kennon K, Bilton Lahaut K, Makuka GJ, Ngu R, Obiesie S, Richmond C, Singh-Phulgenda S, Strudwick S, Tyrrell CSB, Schwinn A, King D, Newton PN, Price RN, Merson L, Stepniewska K, and Guérin PJ
- Abstract
Background: Since the coronavirus disease 2019 (COVID-19) outbreak was first reported in December 2019, many independent trials have been planned that aim to answer similar questions. Tools allowing researchers to review studies already underway can facilitate collaboration, cooperation and harmonisation. The Infectious Diseases Data Observatory (IDDO) has undertaken a living systematic review (LSR) to provide an open, accessible and frequently updated resource summarising characteristics of COVID-19 study registrations. Methods: Review of all eligible trial records identified by systematic searches as of 3 April 2020 and initial synthesis of clinical study characteristics were conducted. In partnership with Exaptive, an open access, cloud-based knowledge graph has been created using the results. Results: There were 728 study registrations which met eligibility criteria and were still active. Median (25
th , 75th percentile) sample size was 130 (60, 400) for all studies and 134 (70, 300) for RCTs. Eight lower middle and low income countries were represented among the planned recruitment sites. Overall 109 pharmacological interventions or advanced therapy medicinal products covering 23 drug categories were studied. Majority (57%, 62/109) of them were planned only in one study arm, either alone or in combination with other interventions. There were 49 distinct combinations studied with 90% (44/49) of them administered in only one or two study arms. The data and interactive platform are available at https://iddo.cognitive.city/. Conclusions: Baseline review highlighted that the majority of investigations in the first three months of the outbreak were small studies with unique treatment arms, likely to be unpowered to provide solid evidence. The continued work of this LSR will allow a more dependable overview of interventions tested, predict the likely strength of evidence generated, allow fast and informative filtering of relevant trials for specific user groups and provide the rapid guidance needed by investigators and funders to avoid duplication of efforts., Competing Interests: No competing interests were disclosed., (Copyright: © 2020 Maguire BJ et al.)- Published
- 2020
- Full Text
- View/download PDF
23. Learning from listeria: safer food for all.
- Author
-
Salama PJ, Embarek PKB, Bagaria J, and Fall IS
- Subjects
- Humans, South Africa epidemiology, Disease Outbreaks prevention & control, Food Safety, Listeria, Listeriosis epidemiology, Listeriosis prevention & control
- Published
- 2018
- Full Text
- View/download PDF
24. The need for commissioning circumcision services for non-therapeutic indications in the NHS: lessons from an incident investigation in Oxford.
- Author
-
Paranthaman K, Bagaria J, and O'Moore E
- Subjects
- Anti-Bacterial Agents therapeutic use, Child, Child, Preschool, Circumcision, Male methods, England, Humans, Infant, Interviews as Topic, Male, Needs Assessment, Religion and Medicine, State Medicine, Treatment Outcome, Circumcision, Male adverse effects, Islam
- Abstract
Introduction: Male circumcision for religious reasons is not available in the NHS. In this report, we present the results of an investigation conducted by the Thames Valley Health Protection Unit (TVHPU) at an unregulated circumcision 'camp' in Oxford in 2006., Methods: A detailed investigation was initiated following notification by a general practitioner of two children with circumcision-related complications at a 'camp'. Telephone interviews were conducted with the 'camp' organizers, the operating surgeon, GPs and paediatric surgeons. A field visit was carried out by TVHPU staff to assess implementation of infection control practices., Results: Thirty-two children were circumcised over a 3 day period in the library of an Islamic faith school by a single, medically qualified individual. Among the 29 children with follow-up information, 13 (44.8%) developed complications requiring medical intervention. Information obtained from interviews and the field visit confirmed the lack of implementation of standard infection control practices., Conclusion: This incident highlights the harm associated with circumcision in young children by unregulated operators due to lack of compliance with best surgical and infection control guidance. There is an urgent need for commissioning circumcision services for religious reasons in the NHS.
- Published
- 2011
- Full Text
- View/download PDF
25. Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study.
- Author
-
Kumarasamy KK, Toleman MA, Walsh TR, Bagaria J, Butt F, Balakrishnan R, Chaudhary U, Doumith M, Giske CG, Irfan S, Krishnan P, Kumar AV, Maharjan S, Mushtaq S, Noorie T, Paterson DL, Pearson A, Perry C, Pike R, Rao B, Ray U, Sarma JB, Sharma M, Sheridan E, Thirunarayan MA, Turton J, Upadhyay S, Warner M, Welfare W, Livermore DM, and Woodford N
- Subjects
- Drug Resistance, Microbial genetics, Enterobacteriaceae drug effects, Humans, India epidemiology, Pakistan epidemiology, Plasmids genetics, Polymerase Chain Reaction, Travel, United Kingdom epidemiology, Drug Resistance, Microbial physiology, Enterobacteriaceae genetics, Enterobacteriaceae Infections epidemiology
- Abstract
Background: Gram-negative Enterobacteriaceae with resistance to carbapenem conferred by New Delhi metallo-beta-lactamase 1 (NDM-1) are potentially a major global health problem. We investigated the prevalence of NDM-1, in multidrug-resistant Enterobacteriaceae in India, Pakistan, and the UK., Methods: Enterobacteriaceae isolates were studied from two major centres in India--Chennai (south India), Haryana (north India)--and those referred to the UK's national reference laboratory. Antibiotic susceptibilities were assessed, and the presence of the carbapenem resistance gene bla(NDM-1) was established by PCR. Isolates were typed by pulsed-field gel electrophoresis of XbaI-restricted genomic DNA. Plasmids were analysed by S1 nuclease digestion and PCR typing. Case data for UK patients were reviewed for evidence of travel and recent admission to hospitals in India or Pakistan., Findings: We identified 44 isolates with NDM-1 in Chennai, 26 in Haryana, 37 in the UK, and 73 in other sites in India and Pakistan. NDM-1 was mostly found among Escherichia coli (36) and Klebsiella pneumoniae (111), which were highly resistant to all antibiotics except to tigecycline and colistin. K pneumoniae isolates from Haryana were clonal but NDM-1 producers from the UK and Chennai were clonally diverse. Most isolates carried the NDM-1 gene on plasmids: those from UK and Chennai were readily transferable whereas those from Haryana were not conjugative. Many of the UK NDM-1 positive patients had travelled to India or Pakistan within the past year, or had links with these countries., Interpretation: The potential of NDM-1 to be a worldwide public health problem is great, and co-ordinated international surveillance is needed., (Copyright (c) 2010 Elsevier Ltd. All rights reserved.)
- Published
- 2010
- Full Text
- View/download PDF
26. Hepatitis A cases in a travelling community in southeast England.
- Author
-
Carnicer-Pont D, Bagaria J, Paranthaman K, Smith A, Barber S, and Bernhaut J
- Subjects
- Adolescent, Adult, Child, Child, Preschool, Contact Tracing, England epidemiology, Female, Hepatitis A transmission, Hepatitis A Vaccines administration & dosage, Humans, Immunoglobulins, Intravenous administration & dosage, Male, Middle Aged, Pregnancy, Pregnancy Complications, Infectious prevention & control, Schools, Hepatitis A epidemiology, Transients and Migrants
- Published
- 2006
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.